These findings are consistent with previous reports on the prognostic value of CAIX for early I/II stage resected NSCLC, in which the percentage of CAIX-positive cells was significantly associated with decreased OS (Kim et al, 2004). The gene discussed is CA9; the disease is non-small cell lung carcinoma.